10:57 IST
BSE
Other Announcement
ANG Lifesciences India Other Announcement
ANG Lifesciences India Ltd has filed its quarterly shareholding pattern as required under SEBI Regulation 31(1)(b).
ANG Lifesciences India Ltd
- Share price
- ₹40.27
- Market cap
- ₹52.59 Cr
- Revenue (annual)
- ₹92.89 Cr
- Net profit (annual)
- ₹-11.08 Cr
- P/E (TTM)
- -4.0×Sector 50.4×
- Promoter holding
- 70.60%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 2Other Announcement 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
6 announcements
22:56 IST
BSE
Annual Report
ANG Lifesciences India Annual Report
ANG Lifesciences India Limited has submitted its Annual Report for the financial year 2025-26, including the notice convening its 20th Annual General Meeting.
20:33 IST
BSE
Annual General Meeting
ANG Lifesciences India Annual General Meeting
ANG Lifesciences India Limited has scheduled its 20th Annual General Meeting for September 30, 2026, to be conducted via Video Conference.
20:26 IST
BSE
Board Meeting Outcome
ANG Lifesciences India Board Meeting Outcome
ANG Lifesciences announced the outcome of its board meeting, approving the Board's report, appointing a cost auditor, and scheduling the 20th AGM for September 30, 2026.
18:25 IST
BSE
Financial Results
ANG Lifesciences India Q1 FY27 Results: Net Loss of ₹4.2 Cr, Loss Widens
ANG Lifesciences India Ltd reported revenue from operations of ₹15.3 Cr (-37.8% YoY) and a net loss of ₹4.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹4.2 Cr
22:16 IST
BSE
Financial Results
ANG Lifesciences India Q4 FY26 Results: Net Loss of ₹1.4 Cr, Loss Narrows
ANG Lifesciences India Ltd reported revenue from operations of ₹23.5 Cr (+39.9% YoY) and a net loss of ₹1.4 Cr for Q4 FY26.
- Key figure
- Net loss ₹1.4 Cr